AC Immune SA - ADR Financials

$2.86

$-0.07 (-2.39%)

As on 04-Sep-2026 16:00EDT

Market cap

$284 Mln

Revenue (TTM)

$18 Mln

P/E Ratio

--

P/B Ratio

6.5

Div. Yield

0 %

Annual
Quarterly

Cashflow (CHF Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-66.15	65.84	-60.41	-73.57	-65.69
Cash Flow from Investing Activities	--	60.69	-105.29	65.65	23.76	-53.66
Cash from Financing Activities	--	-0.97	-1.12	43.25	-1.35	40.75
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS (CHF)	-0.43	-0.70	-0.50	-0.64	-0.85	-0.92
Cash EPS (CHF)	--	-0.67	-0.48	-0.62	-0.82	-0.89
Adjusted Book Value (CHF)	--	0.44	1.11	1.91	2.02	2.93
Dividend per Share (CHF)	--	--	--	--	--	--
Cash Flow per Share (CHF)	--	-0.65	0.65	-0.72	-0.88	-0.83
Free Cash Flow per Share (CHF)	--	-0.66	0.65	-0.73	-0.89	-0.86

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-84.28	-36.13	-32.29	-34.80	-32.26
ROE (%)	-107.75	-89.62	-37.31	-32.90	-35.29	-32.63
ROA (%)	-15.99	-36.56	-24.61	-29.41	-31.63	-29.19
EBIT Margin (%)	-172.39	-1,966.30	-185.95	-365.16	-1,788.69	-7,670.76
Net Margin (%)	-246.49	-1,971.65	-186.44	-366.41	-1,798.04	-7,732.63
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-39.45	-0.87	0.85	2.76	3.17	-0.94
EBIT Growth (%)	40.04	-38.35	6.04	23.21	2.80	-18.20
Net Profit Growth (%)	14.56	-38.36	6.12	23.35	3.07	-17.89
EPS Growth (%)	13.75	-0.38	0.22	0.24	0.08	-0.08
Book Value Growth (%)	-52.01	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.10	0.05	0.02	0.02	0.01
Short term debt to equity ratio	0.02	0.02	0.01	0.00	0.00	0.00
Current Ratio	0.93	1.02	1.71	9.22	11.16	10.12
Quick Ratio	0.93	--	--	9.26	11.16	10.19
Interest Coverage	-200.97	-367.83	-381.80	-307.09	-198.27	-124.63

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	77.93	37.45	4.02	101.66	10.37	103.28
Asset Turnover	0.06	0.02	0.13	0.08	0.02	0.00
Receivable days	--	124.56	107.97	190.68	64.19	496.41
Inventory Days	--	--	-3.63	-2.08	-4.25	-9.74
Payable days	--	--	12.66	8.72	8.87	12.28
Cash Conversion Cycle	--	--	91.68	179.88	51.06	474.39

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.